Enzo Health, a Lehi, UT-based provider of an AI-driven platform for home health and post-acute care, raised $20M in Series A funding.

The round was led by N47. Existing investors Gradient, Tandem Ventures, and Rigby Watts also participated.

The raise brought the total amount to $26M.

The company intends to use the funds to expand into the skilled nursing and hospice sectors by extending its AI-driven platform to address the unique clinical, operational, and regulatory workflows of each setting, enabling providers to operate more efficiently while maintaining high-quality care.

Led by CEO Zach Newman, Enzo Health is an AI-driven platform built specifically for home health. Connecting front office, clinical, and back office operations in one system, Enzo automates each stage of the patient journey from referral to revenue, helping agencies take on more patients, protect their reimbursement, and give their clinicians time to focus on care. It includes:

• Enzo Intake, which analyzes referrals instantly, converts faxes, emails, and PDFs into structured data, and checks eligibility in seconds before staff review is needed.
• Enzo Scribe, which delivers OASIS validation and AI-assisted documentation in real-time during a visit, so clinicians finish charting before they leave the patient’s home.
• Enzo QA, which continuously reviews charts for clinical and regulatory accuracy, catching issues before they affect reimbursement or compliance.

source[FinSMEs]